Sanofi is here to support you and your patients.
Ask us your questions about our products, patient materials or organising a meeting.
There is an intense desire to participate in fasting during Ramadan, even among the people who could seek exemption1. Discover the ORION study and the 2021 IDF-DAR Practical guidance.
Summary
Download a summary of the ORION study. Real-world safety and effectiveness of Toujeo® in patients with Type 2 Diabetes who choose to fast during Ramadan.
Full Publication
Read the full publication of the ORION observational study in patients with Type 2 Diabetes who choose to fast during Ramadan.
Toujeo
Toujeo® is indicated as treatment of diabetes mellitus in adults, adolescents and children from the age of 6 years.
Patient Website
Find resources and support for your patients on Toujeo®. Help patients understand the basics of living and staying well with diabetes and how to have a positive start and experience with the medication prescribed to them.
MAT-XU-2205631 (v3.0)
Date of Preparation: September 2023
